EGF and cancer: Nanoparticles can serve as carriers for drugs, chemotherapeutics, or monoclonal antibodies that selectively bind to receptors on the surface of cancer cells and also contain other ligands on their surface, such as folic acid, hyaluronic acid, arginylglycyl-aspartate tripeptide (RGD), or epidermal growth factor (EGF).